Skip Navigation LinksHome > February 2013 - Volume 33 - Issue 1 > Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Ago...
Journal of Clinical Psychopharmacology:
doi: 10.1097/JCP.0b013e3182793843
Letters to the Editors

Effects of the Cannabinoid-1 Receptor Antagonist/Inverse Agonist Rimonabant on Satiety Signaling in Overweight People with Schizophrenia: A Randomized, Double-Blind, Pilot Study

Warren, Kimberly R. PhD; Buchanan, Robert W. MD; Feldman, Stephanie MSW, LCSW-C; Conley, Robert R. MD; Linthicum, Jared MS; Ball, Mary Patricia RN, C, MS; Liu, Fang MS; McMahon, Robert P. PhD; Gorelick, David A. MD, PhD; Huestis, Marilyn A. PhD; Kelly, Deanna L. PharmD, BCPP



The author of an article published in the February 2013 issue of the Journal of Clinical Psychopharmacology notified us of an updated affiliation which was not included.

The correct affiliation for Kimberly R. Warren, PhD is:

Department of Psychology, Morgan State University, Baltimore, Maryland; Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, Maryland.

Journal of Clinical Psychopharmacology. 36(1):26, February 2016.


Article Tools


Article Level Metrics